• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝炎犬的肝脏和血浆内皮素-1

Hepatic and Plasma Endothelin-1 in Dogs with Chronic Hepatitis.

作者信息

Sakamoto Y, Sakai M, Watari T

机构信息

Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Fujisawa, Kanagawa, Japan.

出版信息

J Vet Intern Med. 2017 May;31(3):764-769. doi: 10.1111/jvim.14687. Epub 2017 Mar 14.

DOI:10.1111/jvim.14687
PMID:28295621
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5435058/
Abstract

BACKGROUND

Endothelin (ET)-1 is a 21-amino-acid peptide with potent vasoactive properties, which increases intrahepatic resistance in patients with chronic hepatitis (CH) or cirrhosis. ET-1 concentrations have not been investigated in dogs with CH.

HYPOTHESIS/OBJECTIVES: This study compared hepatic and plasma ET-1 levels in healthy dogs and in dogs with CH, and examined the relationship between the plasma ET-1 level and portal vein pressure in dogs with CH.

ANIMALS

Fourteen healthy dogs and twenty dogs with CH were used in this study.

METHODS

Prospective case-control study. Hepatic ET-1 mRNA expression was determined by real-time reverse transcription polymerase chain reaction, and hepatic and plasma ET-1 levels were assessed using ELISA. Splenic pulp pressure (SPP), as an indicator of portal vein pressure, was measured laparoscopically.

RESULTS

Hepatic ET-1 mRNA levels were 3.7 times higher in dogs with CH than in healthy dogs (P = .008). The median hepatic and plasma ET-1 protein levels were significantly higher in dogs with CH than in healthy dogs (13.20 pg/mg wet liver vs. 3.42 pg/mg wet liver, P = .004, and 0.99 pg/mL vs. 0.71 pg/mL, P = .013, respectively). Moreover, there was a weak but significant correlation between plasma ET-1 level and SPP in dogs with CH (P = .036; r = 0.53).

CONCLUSIONS AND CLINICAL IMPORTANCE

The results indicate that ET-1 might play an important role in the pathogenesis of portal hypertension caused by CH.

摘要

背景

内皮素(ET)-1是一种具有强大血管活性特性的21个氨基酸的肽,可增加慢性肝炎(CH)或肝硬化患者的肝内阻力。尚未对患CH的犬的ET-1浓度进行研究。

假设/目的:本研究比较了健康犬和患CH的犬的肝脏和血浆ET-1水平,并研究了患CH的犬的血浆ET-1水平与门静脉压力之间的关系。

动物

本研究使用了14只健康犬和20只患CH的犬。

方法

前瞻性病例对照研究。通过实时逆转录聚合酶链反应测定肝脏ET-1 mRNA表达,并使用酶联免疫吸附测定法评估肝脏和血浆ET-1水平。通过腹腔镜测量脾髓压力(SPP),作为门静脉压力的指标。

结果

患CH的犬的肝脏ET-1 mRNA水平比健康犬高3.7倍(P = .008)。患CH的犬的肝脏和血浆ET-1蛋白水平中位数显著高于健康犬(湿肝组织分别为13.20 pg/mg vs. 3.42 pg/mg,P = .004;血浆分别为0.99 pg/mL vs. 0.71 pg/mL,P = .013)。此外,患CH的犬的血浆ET-1水平与SPP之间存在弱但显著的相关性(P = .036;r = 0.53)。

结论及临床意义

结果表明,ET-1可能在CH所致门静脉高压的发病机制中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/99f2f30b3c4f/JVIM-31-764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/6a6a0898608f/JVIM-31-764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/3a681b660eda/JVIM-31-764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/0fe132cc0f02/JVIM-31-764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/99f2f30b3c4f/JVIM-31-764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/6a6a0898608f/JVIM-31-764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/3a681b660eda/JVIM-31-764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/0fe132cc0f02/JVIM-31-764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1e/5435058/99f2f30b3c4f/JVIM-31-764-g004.jpg

相似文献

1
Hepatic and Plasma Endothelin-1 in Dogs with Chronic Hepatitis.慢性肝炎犬的肝脏和血浆内皮素-1
J Vet Intern Med. 2017 May;31(3):764-769. doi: 10.1111/jvim.14687. Epub 2017 Mar 14.
2
Elevated endothelin-1 expression in dogs with heartworm disease.感染犬心丝虫病的犬体内内皮素-1表达升高。
J Vet Med Sci. 2005 Nov;67(11):1155-61. doi: 10.1292/jvms.67.1155.
3
Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals.获得性门腔静脉侧支循环犬的血浆肾素活性和醛固酮浓度。
J Vet Intern Med. 2020 Jan;34(1):139-144. doi: 10.1111/jvim.15661. Epub 2019 Nov 14.
4
Big endothelin-1 as a tumour marker for canine haemangiosarcoma.大内皮素-1作为犬血管肉瘤的肿瘤标志物。
Vet J. 2015 Jun;204(3):269-74. doi: 10.1016/j.tvjl.2015.03.024. Epub 2015 Mar 25.
5
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.慢性肝病患者肝组织中内皮素-1水平与疾病严重程度及腹水相关。
Am J Gastroenterol. 2000 Jan;95(1):199-203. doi: 10.1111/j.1572-0241.2000.01684.x.
6
Hepatic concentrations of copper and other metals in dogs with and without chronic hepatitis.患有和未患有慢性肝炎的犬类肝脏中铜及其他金属的浓度。
J Small Anim Pract. 2016 Dec;57(12):703-709. doi: 10.1111/jsap.12591. Epub 2016 Oct 16.
7
Association of circulating microRNA-122 and microRNA-29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers.循环微小RNA-122和微小RNA-29a与拉布拉多猎犬肝纤维化分期及慢性肝炎进展的相关性
J Vet Intern Med. 2019 Jan;33(1):151-157. doi: 10.1111/jvim.15366. Epub 2018 Dec 11.
8
Portal Vein/Aorta Ratio in Dogs with Acquired Portosystemic Collaterals.患有后天性门体侧支循环的犬类的门静脉/主动脉比率
J Vet Intern Med. 2017 Sep;31(5):1382-1387. doi: 10.1111/jvim.14802. Epub 2017 Aug 14.
9
Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.特发性门静脉高压症和肝硬化患者中内皮素-1的肝脏定位
Liver Transpl. 2000 Sep;6(5):596-602. doi: 10.1053/jlts.2000.9735.
10
Hepatic copper concentrations in Labrador Retrievers with and without chronic hepatitis: 72 cases (1980-2010).患有和未患有慢性肝炎的拉布拉多寻回犬的肝脏铜浓度:72例病例(1980 - 2010年)
J Am Vet Med Assoc. 2013 Feb 1;242(3):372-80. doi: 10.2460/javma.242.3.372.

引用本文的文献

1
Prognostic indicators in dogs with intra-hepatic portal hypertension.犬肝内门脉高压的预后指标。
Can Vet J. 2023 Feb;64(2):174-180.
2
Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs.减肥计划对肥胖犬生化和免疫指标、血清瘦素水平及心血管参数的影响
Front Vet Sci. 2020 Aug 6;7:398. doi: 10.3389/fvets.2020.00398. eCollection 2020.
3
Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals.获得性门腔静脉侧支循环犬的血浆肾素活性和醛固酮浓度。

本文引用的文献

1
Three minimally invasive methods of measuring of portal vein pressure in healthy dogs.三种测量健康犬门静脉压力的微创方法。
J Vet Med Sci. 2012 Oct;74(10):1299-302. doi: 10.1292/jvms.11-0549. Epub 2012 Jun 1.
2
Serum and bronchoalveolar lavage fluid endothelin-1 concentrations as diagnostic biomarkers of canine idiopathic pulmonary fibrosis.血清和支气管肺泡灌洗液内皮素-1 浓度作为犬特发性肺纤维化的诊断生物标志物。
J Vet Intern Med. 2011 Sep-Oct;25(5):990-6. doi: 10.1111/j.1939-1676.2011.0766.x. Epub 2011 Jul 22.
3
Portal hypertension: pathophysiology, diagnosis, and treatment.
J Vet Intern Med. 2020 Jan;34(1):139-144. doi: 10.1111/jvim.15661. Epub 2019 Nov 14.
4
ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.ACVIM 共识声明:犬慢性肝炎的诊断与治疗。
J Vet Intern Med. 2019 May;33(3):1173-1200. doi: 10.1111/jvim.15467. Epub 2019 Mar 7.
5
Gallbladder Agenesis in 17 Dogs: 2006-2016.2006 - 2016年17只犬的胆囊缺如
J Vet Intern Med. 2018 Jan;32(1):188-194. doi: 10.1111/jvim.15034.
6
Hepatic Fibrosis in Dogs.犬肝纤维化
J Vet Intern Med. 2018 Jan;32(1):26-41. doi: 10.1111/jvim.14891. Epub 2017 Nov 30.
7
Portal Vein/Aorta Ratio in Dogs with Acquired Portosystemic Collaterals.患有后天性门体侧支循环的犬类的门静脉/主动脉比率
J Vet Intern Med. 2017 Sep;31(5):1382-1387. doi: 10.1111/jvim.14802. Epub 2017 Aug 14.
门静脉高压症:病理生理学、诊断和治疗。
J Vet Intern Med. 2011 Mar-Apr;25(2):169-86. doi: 10.1111/j.1939-1676.2011.00691.x.
4
Expression of fibrosis-related genes in canine chronic hepatitis.纤维化相关基因在犬慢性肝炎中的表达。
Vet Pathol. 2011 Jul;48(4):839-45. doi: 10.1177/0300985810388523. Epub 2010 Nov 29.
5
Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature.儿童期特发性门静脉高压导致危及生命的脾功能亢进:病例报告及文献复习。
BMC Gastroenterol. 2010 Oct 20;10:122. doi: 10.1186/1471-230X-10-122.
6
Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.肝脏内皮功能障碍和异常血管生成:门静脉高压治疗的新靶点。
J Hepatol. 2010 Sep;53(3):558-67. doi: 10.1016/j.jhep.2010.03.021. Epub 2010 Jun 1.
7
Acquired portal collateral circulation in the dog and cat.犬猫的后天性门静脉侧支循环
Vet Radiol Ultrasound. 2010 Jan-Feb;51(1):25-33. doi: 10.1111/j.1740-8261.2009.01616.x.
8
Plasma atrial natriuretic peptide (proANP 31-67), B-type natriuretic peptide (Nt-proBNP) and endothelin-1 (ET-1) concentrations in dogs with chronic degenerative valvular disease (CDVD).患有慢性退行性瓣膜病(CDVD)的犬血浆心房利钠肽(proANP 31 - 67)、B型利钠肽(Nt - proBNP)和内皮素 - 1(ET - 1)浓度
Vet Res Commun. 2009 Sep;33 Suppl 1:197-200. doi: 10.1007/s11259-009-9282-8.
9
Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.内皮素拮抗剂对门静脉高压小鼠的作用:对肝病中内皮素受体特异性信号传导的影响
Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G27-33. doi: 10.1152/ajpgi.90405.2008. Epub 2009 Mar 19.
10
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.MIQE指南:实时定量PCR实验发表的最低信息要求
Clin Chem. 2009 Apr;55(4):611-22. doi: 10.1373/clinchem.2008.112797. Epub 2009 Feb 26.